

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 8.37004462 |
| 2 | * keratinocyte proliferation (GO:0043616) | 6.43167107 |
| 3 | cell-substrate junction assembly (GO:0007044) | 5.76095633 |
| 4 | regulation of keratinocyte proliferation (GO:0010837) | 5.46667994 |
| 5 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.44894294 |
| 6 | intermediate filament organization (GO:0045109) | 5.41206885 |
| 7 | establishment of skin barrier (GO:0061436) | 5.28823495 |
| 8 | regulation of water loss via skin (GO:0033561) | 5.28728197 |
| 9 | hemidesmosome assembly (GO:0031581) | 5.23122093 |
| 10 | keratinocyte development (GO:0003334) | 5.10856292 |
| 11 | epidermis development (GO:0008544) | 5.04270080 |
| 12 | surfactant homeostasis (GO:0043129) | 4.84249083 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.81102197 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 4.81102197 |
| 15 | intestinal cholesterol absorption (GO:0030299) | 4.71180253 |
| 16 | gap junction assembly (GO:0016264) | 4.63532605 |
| 17 | establishment of tissue polarity (GO:0007164) | 4.61330251 |
| 18 | establishment of planar polarity (GO:0001736) | 4.61330251 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 4.59483245 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.59483245 |
| 21 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.40006139 |
| 22 | polarized epithelial cell differentiation (GO:0030859) | 4.29093536 |
| 23 | chemical homeostasis within a tissue (GO:0048875) | 4.27296012 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 4.21706057 |
| 25 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.16346169 |
| 26 | positive regulation of epidermis development (GO:0045684) | 4.14606624 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 4.05740807 |
| 28 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.00392660 |
| 29 | intestinal absorption (GO:0050892) | 3.98186939 |
| 30 | regulation of cholesterol homeostasis (GO:2000188) | 3.97273991 |
| 31 | regulation of hair follicle development (GO:0051797) | 3.93099078 |
| 32 | multicellular organismal water homeostasis (GO:0050891) | 3.92995844 |
| 33 | ectoderm development (GO:0007398) | 3.91000686 |
| 34 | cysteine metabolic process (GO:0006534) | 3.90536304 |
| 35 | interferon-gamma secretion (GO:0072643) | 3.88811302 |
| 36 | regulation of keratinocyte differentiation (GO:0045616) | 3.84833809 |
| 37 | phospholipid efflux (GO:0033700) | 3.76389193 |
| 38 | peptide cross-linking (GO:0018149) | 3.72194290 |
| 39 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.71989982 |
| 40 | keratinization (GO:0031424) | 3.67105397 |
| 41 | hypotonic response (GO:0006971) | 3.66803394 |
| 42 | hormone catabolic process (GO:0042447) | 3.62463937 |
| 43 | indole-containing compound catabolic process (GO:0042436) | 3.58144926 |
| 44 | indolalkylamine catabolic process (GO:0046218) | 3.58144926 |
| 45 | tryptophan catabolic process (GO:0006569) | 3.58144926 |
| 46 | water homeostasis (GO:0030104) | 3.55782785 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 3.54381930 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 3.53874063 |
| 49 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.53749966 |
| 50 | regulation of phospholipase A2 activity (GO:0032429) | 3.50356362 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.48744907 |
| 52 | tryptophan metabolic process (GO:0006568) | 3.47989257 |
| 53 | regulation of bile acid biosynthetic process (GO:0070857) | 3.46889597 |
| 54 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.46115656 |
| 55 | lateral sprouting from an epithelium (GO:0060601) | 3.45553310 |
| 56 | regulation of epidermis development (GO:0045682) | 3.44629623 |
| 57 | diterpenoid biosynthetic process (GO:0016102) | 3.44605614 |
| 58 | skin morphogenesis (GO:0043589) | 3.44501187 |
| 59 | bile acid biosynthetic process (GO:0006699) | 3.44155605 |
| 60 | urea metabolic process (GO:0019627) | 3.43448846 |
| 61 | urea cycle (GO:0000050) | 3.43448846 |
| 62 | kynurenine metabolic process (GO:0070189) | 3.40507086 |
| 63 | epithelial cell-cell adhesion (GO:0090136) | 3.37973975 |
| 64 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.35399701 |
| 65 | glyoxylate metabolic process (GO:0046487) | 3.34799233 |
| 66 | drug transmembrane transport (GO:0006855) | 3.34265571 |
| 67 | negative regulation of lipase activity (GO:0060192) | 3.33729221 |
| 68 | bile acid and bile salt transport (GO:0015721) | 3.32930698 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.32329551 |
| 70 | homocysteine metabolic process (GO:0050667) | 3.31316918 |
| 71 | intermediate filament cytoskeleton organization (GO:0045104) | 3.30792973 |
| 72 | transcytosis (GO:0045056) | 3.29530306 |
| 73 | regulation of hair cycle (GO:0042634) | 3.29522347 |
| 74 | cellular glucuronidation (GO:0052695) | 3.29401698 |
| 75 | cell adhesion mediated by integrin (GO:0033627) | 3.29261679 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.26736480 |
| 77 | COPII vesicle coating (GO:0048208) | 3.26290649 |
| 78 | * keratinocyte differentiation (GO:0030216) | 3.26271784 |
| 79 | primary alcohol catabolic process (GO:0034310) | 3.24574526 |
| 80 | linoleic acid metabolic process (GO:0043651) | 3.22063216 |
| 81 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.21361765 |
| 82 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.21191772 |
| 83 | negative regulation of epidermis development (GO:0045683) | 3.19624533 |
| 84 | protein carboxylation (GO:0018214) | 3.17356606 |
| 85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.17356606 |
| 86 | xenobiotic catabolic process (GO:0042178) | 3.17270023 |
| 87 | intermediate filament-based process (GO:0045103) | 3.16279580 |
| 88 | reverse cholesterol transport (GO:0043691) | 3.15008099 |
| 89 | ethanol metabolic process (GO:0006067) | 3.14779093 |
| 90 | glucuronate metabolic process (GO:0019585) | 3.14720994 |
| 91 | uronic acid metabolic process (GO:0006063) | 3.14720994 |
| 92 | bile acid metabolic process (GO:0008206) | 3.13928041 |
| 93 | regulation of cardioblast differentiation (GO:0051890) | 3.11072625 |
| 94 | acylglycerol homeostasis (GO:0055090) | 3.10216690 |
| 95 | triglyceride homeostasis (GO:0070328) | 3.10216690 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 3.09666146 |
| 97 | sphingoid metabolic process (GO:0046519) | 3.09518227 |
| 98 | intestinal epithelial cell development (GO:0060576) | 3.09162983 |
| 99 | positive regulation of hair cycle (GO:0042635) | 3.08958044 |
| 100 | positive regulation of hair follicle development (GO:0051798) | 3.08958044 |
| 101 | regulation of cholesterol esterification (GO:0010872) | 3.08534542 |
| 102 | nitrogen cycle metabolic process (GO:0071941) | 3.07273918 |
| 103 | cell junction assembly (GO:0034329) | 3.05033058 |
| 104 | negative regulation of cholesterol transport (GO:0032375) | 3.02961248 |
| 105 | negative regulation of sterol transport (GO:0032372) | 3.02961248 |
| 106 | lysine metabolic process (GO:0006553) | 3.02010357 |
| 107 | lysine catabolic process (GO:0006554) | 3.02010357 |
| 108 | drug catabolic process (GO:0042737) | 3.00761024 |
| 109 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.99126675 |
| 110 | regulation of protein activation cascade (GO:2000257) | 2.99017834 |
| 111 | serine family amino acid catabolic process (GO:0009071) | 2.97762001 |
| 112 | regulation of epidermal cell differentiation (GO:0045604) | 2.96812973 |
| 113 | cell communication involved in cardiac conduction (GO:0086065) | 2.96415811 |
| 114 | response to nitrosative stress (GO:0051409) | 2.95678566 |
| 115 | alpha-linolenic acid metabolic process (GO:0036109) | 2.94954891 |
| 116 | cell junction organization (GO:0034330) | 2.94293378 |
| 117 | complement activation, alternative pathway (GO:0006957) | 2.93214656 |
| 118 | aromatic amino acid family metabolic process (GO:0009072) | 2.93084955 |
| 119 | atrioventricular valve morphogenesis (GO:0003181) | 2.91175324 |
| 120 | fibrinolysis (GO:0042730) | 2.90580550 |
| 121 | COPI coating of Golgi vesicle (GO:0048205) | 2.90162658 |
| 122 | Golgi transport vesicle coating (GO:0048200) | 2.90162658 |
| 123 | tight junction assembly (GO:0070830) | 2.89757045 |
| 124 | apical protein localization (GO:0045176) | 2.88888481 |
| 125 | benzene-containing compound metabolic process (GO:0042537) | 2.88661165 |
| 126 | regulation of transforming growth factor beta production (GO:0071634) | 2.87971264 |
| 127 | carnitine metabolic process (GO:0009437) | 2.86964668 |
| 128 | protein localization to endosome (GO:0036010) | 2.86939623 |
| 129 | sphingosine metabolic process (GO:0006670) | 2.85768875 |
| 130 | imidazole-containing compound metabolic process (GO:0052803) | 2.85544929 |
| 131 | mesodermal cell differentiation (GO:0048333) | 2.85493742 |
| 132 | cell-cell junction assembly (GO:0007043) | 2.84149843 |
| 133 | regulation of complement activation (GO:0030449) | 2.81677973 |
| 134 | plasma lipoprotein particle remodeling (GO:0034369) | 2.81584297 |
| 135 | protein-lipid complex remodeling (GO:0034368) | 2.81584297 |
| 136 | macromolecular complex remodeling (GO:0034367) | 2.81584297 |
| 137 | lipoprotein metabolic process (GO:0042157) | 2.81301340 |
| 138 | regulation of fibrinolysis (GO:0051917) | 2.80668526 |
| 139 | endosome organization (GO:0007032) | 2.79777067 |
| 140 | tyrosine metabolic process (GO:0006570) | 2.78489106 |
| 141 | 4-hydroxyproline metabolic process (GO:0019471) | 2.78125008 |
| 142 | morphogenesis of embryonic epithelium (GO:0016331) | 2.77061045 |
| 143 | flavonoid metabolic process (GO:0009812) | 2.76388888 |
| 144 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.75756999 |
| 145 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.75561657 |
| 146 | * epidermal cell differentiation (GO:0009913) | 2.73926524 |
| 147 | peptide catabolic process (GO:0043171) | 2.72944604 |
| 148 | glutathione derivative metabolic process (GO:1901685) | 2.72457730 |
| 149 | glutathione derivative biosynthetic process (GO:1901687) | 2.72457730 |
| 150 | molting cycle (GO:0042303) | 2.72344690 |
| 151 | hair cycle (GO:0042633) | 2.72344690 |
| 152 | negative regulation of fibrinolysis (GO:0051918) | 2.69995573 |
| 153 | retinal metabolic process (GO:0042574) | 2.69602913 |
| 154 | cholesterol homeostasis (GO:0042632) | 2.69564853 |
| 155 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.68785215 |
| 156 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.68765088 |
| 157 | axonemal dynein complex assembly (GO:0070286) | 2.68590540 |
| 158 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.67604730 |
| 159 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.64496251 |
| 160 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.61126521 |
| 161 | L-serine transport (GO:0015825) | 2.58708918 |
| 162 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.57596684 |
| 163 | epithelium development (GO:0060429) | 2.57260791 |
| 164 | renal filtration (GO:0097205) | 2.56076158 |
| 165 | cardiac conduction (GO:0061337) | 2.55540699 |
| 166 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.54704415 |
| 167 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.52429175 |
| 168 | asymmetric protein localization (GO:0008105) | 2.50921395 |
| 169 | establishment of apical/basal cell polarity (GO:0035089) | 2.49053439 |
| 170 | oocyte development (GO:0048599) | 2.47832287 |
| 171 | skin development (GO:0043588) | 2.46968710 |
| 172 | terpenoid biosynthetic process (GO:0016114) | 2.43193430 |
| 173 | iron ion import (GO:0097286) | 2.43045590 |
| 174 | endodermal cell differentiation (GO:0035987) | 2.41792360 |
| 175 | negative regulation of cell fate specification (GO:0009996) | 2.41299969 |
| 176 | filopodium assembly (GO:0046847) | 2.40407612 |
| 177 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.38189225 |
| 178 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.38140441 |
| 179 | cardiac right ventricle morphogenesis (GO:0003215) | 2.37686873 |
| 180 | regulation of protein localization to cell surface (GO:2000008) | 2.36449345 |
| 181 | genitalia morphogenesis (GO:0035112) | 2.35802063 |
| 182 | retinol metabolic process (GO:0042572) | 2.34417779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.92553933 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.53639076 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.45564118 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.10586679 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63245002 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.39101356 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.94158608 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.59141491 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.43937963 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.42375340 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.30773072 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.30682313 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.25472107 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.12146850 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.10609168 |
| 16 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.10438851 |
| 17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.06509381 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.9682742 |
| 19 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.95551419 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94640019 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92936705 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.92341121 |
| 23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.91874327 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91772832 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.89164804 |
| 26 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.86409949 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.72141785 |
| 28 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.63809004 |
| 29 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.55332196 |
| 30 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.55332196 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54464450 |
| 32 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.48628074 |
| 33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48572821 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.41135275 |
| 35 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.34972380 |
| 36 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.34052596 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33196763 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31744732 |
| 39 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.31370400 |
| 40 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30124563 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29261720 |
| 42 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.27545282 |
| 43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27100733 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26295278 |
| 45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.25087762 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21187377 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19830373 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19718953 |
| 49 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18744429 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17215160 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15681365 |
| 52 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.15000561 |
| 53 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11242362 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10410118 |
| 55 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09635410 |
| 56 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09019064 |
| 57 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.08653321 |
| 58 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99793457 |
| 59 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98201558 |
| 60 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96861045 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96260697 |
| 62 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94966988 |
| 63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94344951 |
| 64 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.94208292 |
| 65 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.92629752 |
| 66 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92453199 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92382973 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91761117 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90754543 |
| 70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90521780 |
| 71 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88534283 |
| 72 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.86693502 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85477096 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84040846 |
| 75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83906822 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83675751 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83355945 |
| 78 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.83052029 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82606888 |
| 80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81837961 |
| 81 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81525372 |
| 82 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80739351 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80692345 |
| 84 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79921184 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79816865 |
| 86 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78755572 |
| 87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.76942522 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73963161 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73378797 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73378797 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72471347 |
| 92 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72435775 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.71962832 |
| 94 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71828100 |
| 95 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.71818802 |
| 96 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.71558479 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.70720296 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.67208823 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 0.67120692 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.66867136 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65636766 |
| 102 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.65304191 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.65249198 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.65047999 |
| 105 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.65020201 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.64757470 |
| 107 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.64510279 |
| 108 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64333504 |
| 109 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.64006411 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63526439 |
| 111 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.61977828 |
| 112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61497687 |
| 113 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61112702 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60948824 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60660889 |
| 116 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.60158559 |
| 117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.60158559 |
| 118 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.60017409 |
| 119 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.58418204 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.58375868 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57254428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.88500481 |
| 2 | MP0002796_impaired_skin_barrier | 4.55198292 |
| 3 | MP0005360_urolithiasis | 4.18546400 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.14736868 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.97723764 |
| 6 | MP0005365_abnormal_bile_salt | 3.84935457 |
| 7 | MP0002254_reproductive_system_inflammat | 3.34380936 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.97621060 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.96433766 |
| 10 | MP0005409_darkened_coat_color | 2.76643547 |
| 11 | MP0005501_abnormal_skin_physiology | 2.69358480 |
| 12 | MP0010678_abnormal_skin_adnexa | 2.55954285 |
| 13 | MP0000383_abnormal_hair_follicle | 2.48289868 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.43700630 |
| 15 | MP0004264_abnormal_extraembryonic_tissu | 2.42912540 |
| 16 | MP0000579_abnormal_nail_morphology | 2.42878372 |
| 17 | MP0003252_abnormal_bile_duct | 2.41392614 |
| 18 | MP0005275_abnormal_skin_tensile | 2.27215481 |
| 19 | * MP0002098_abnormal_vibrissa_morphology | 2.23612538 |
| 20 | * MP0001216_abnormal_epidermal_layer | 2.15372228 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.14620696 |
| 22 | MP0004381_abnormal_hair_follicle | 2.08181154 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.08176841 |
| 24 | MP0005083_abnormal_biliary_tract | 2.07159332 |
| 25 | * MP0002060_abnormal_skin_morphology | 2.05355988 |
| 26 | MP0003195_calcinosis | 1.96378351 |
| 27 | * MP0003453_abnormal_keratinocyte_physiol | 1.92769020 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.86921541 |
| 29 | MP0002009_preneoplasia | 1.75427093 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.73925245 |
| 31 | MP0004272_abnormal_basement_membrane | 1.61551956 |
| 32 | MP0004947_skin_inflammation | 1.58374211 |
| 33 | * MP0010771_integument_phenotype | 1.57981050 |
| 34 | * MP0000377_abnormal_hair_follicle | 1.57493704 |
| 35 | MP0000427_abnormal_hair_cycle | 1.56606290 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.54790066 |
| 37 | MP0000647_abnormal_sebaceous_gland | 1.52082456 |
| 38 | MP0009840_abnormal_foam_cell | 1.47692206 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.41948239 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.41786690 |
| 41 | MP0000537_abnormal_urethra_morphology | 1.40564687 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.39832405 |
| 43 | MP0001346_abnormal_lacrimal_gland | 1.39229792 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 1.33401637 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.31893536 |
| 46 | * MP0000467_abnormal_esophagus_morphology | 1.31359648 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.29642286 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.27576626 |
| 49 | MP0005332_abnormal_amino_acid | 1.27002111 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.23541418 |
| 51 | MP0005451_abnormal_body_composition | 1.20659813 |
| 52 | MP0009053_abnormal_anal_canal | 1.20062787 |
| 53 | MP0003315_abnormal_perineum_morphology | 1.17415532 |
| 54 | MP0003868_abnormal_feces_composition | 1.17212688 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.15534901 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.13495450 |
| 57 | MP0004043_abnormal_pH_regulation | 1.11409041 |
| 58 | MP0000609_abnormal_liver_physiology | 1.11349664 |
| 59 | MP0001191_abnormal_skin_condition | 1.11132679 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.08272789 |
| 61 | MP0000613_abnormal_salivary_gland | 1.03818239 |
| 62 | * MP0000762_abnormal_tongue_morphology | 1.03182408 |
| 63 | * MP0009931_abnormal_skin_appearance | 1.02747858 |
| 64 | MP0000538_abnormal_urinary_bladder | 1.02656326 |
| 65 | MP0001765_abnormal_ion_homeostasis | 0.99700461 |
| 66 | MP0000367_abnormal_coat/_hair | 0.98763494 |
| 67 | MP0001849_ear_inflammation | 0.97156391 |
| 68 | MP0008004_abnormal_stomach_pH | 0.94812854 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 0.94467956 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.90969746 |
| 71 | MP0002166_altered_tumor_susceptibility | 0.88498656 |
| 72 | MP0008789_abnormal_olfactory_epithelium | 0.87716297 |
| 73 | MP0003045_fibrosis | 0.86306992 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 0.85950550 |
| 75 | MP0000462_abnormal_digestive_system | 0.84149738 |
| 76 | * MP0003941_abnormal_skin_development | 0.83505163 |
| 77 | MP0001756_abnormal_urination | 0.82361233 |
| 78 | MP0001851_eye_inflammation | 0.82265213 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.81831761 |
| 80 | MP0009384_cardiac_valve_regurgitation | 0.80914708 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.80876724 |
| 82 | MP0001944_abnormal_pancreas_morphology | 0.80862611 |
| 83 | MP0005248_abnormal_Harderian_gland | 0.80376677 |
| 84 | MP0003950_abnormal_plasma_membrane | 0.79908883 |
| 85 | MP0005408_hypopigmentation | 0.76691619 |
| 86 | MP0005647_abnormal_sex_gland | 0.76674651 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.71642830 |
| 88 | MP0005257_abnormal_intraocular_pressure | 0.71149198 |
| 89 | MP0001243_abnormal_dermal_layer | 0.70898039 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.70889530 |
| 91 | MP0005023_abnormal_wound_healing | 0.70657651 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.70118135 |
| 93 | MP0004885_abnormal_endolymph | 0.68333359 |
| 94 | MP0008260_abnormal_autophagy | 0.65039180 |
| 95 | MP0001881_abnormal_mammary_gland | 0.64915059 |
| 96 | MP0000627_abnormal_mammary_gland | 0.64406086 |
| 97 | MP0000858_altered_metastatic_potential | 0.64238667 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.64232173 |
| 99 | MP0002282_abnormal_trachea_morphology | 0.64146750 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.63310509 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.62106598 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.61124106 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.61057030 |
| 104 | MP0002006_tumorigenesis | 0.60847532 |
| 105 | MP0000003_abnormal_adipose_tissue | 0.59844307 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.59375545 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.59334103 |
| 108 | MP0000470_abnormal_stomach_morphology | 0.59131409 |
| 109 | MP0005499_abnormal_olfactory_system | 0.58534411 |
| 110 | MP0005394_taste/olfaction_phenotype | 0.58534411 |
| 111 | MP0001873_stomach_inflammation | 0.58472517 |
| 112 | MP0005395_other_phenotype | 0.58160212 |
| 113 | MP0005367_renal/urinary_system_phenotyp | 0.58084531 |
| 114 | MP0000516_abnormal_urinary_system | 0.58084531 |
| 115 | * MP0003755_abnormal_palate_morphology | 0.57633130 |
| 116 | MP0002168_other_aberrant_phenotype | 0.56280983 |
| 117 | MP0001764_abnormal_homeostasis | 0.56179505 |
| 118 | MP0003011_delayed_dark_adaptation | 0.55722055 |
| 119 | MP0001340_abnormal_eyelid_morphology | 0.54879050 |
| 120 | MP0006054_spinal_hemorrhage | 0.54293016 |
| 121 | MP0003091_abnormal_cell_migration | 0.53289208 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.52679292 |
| 123 | MP0002249_abnormal_larynx_morphology | 0.51397077 |
| 124 | MP0003718_maternal_effect | 0.51389227 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.46724573 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.46610924 |
| 127 | MP0002089_abnormal_postnatal_growth/wei | 0.45428827 |
| 128 | MP0006138_congestive_heart_failure | 0.44191884 |
| 129 | MP0010030_abnormal_orbit_morphology | 0.43132459 |
| 130 | MP0000013_abnormal_adipose_tissue | 0.40883434 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.38113668 |
| 132 | MP0002233_abnormal_nose_morphology | 0.38084560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 5.64980263 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.47466222 |
| 3 | Plantar hyperkeratosis (HP:0007556) | 4.52218109 |
| 4 | Onycholysis (HP:0001806) | 4.51989912 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.49567609 |
| 6 | Woolly hair (HP:0002224) | 4.45314396 |
| 7 | Ridged nail (HP:0001807) | 4.37276872 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.31692850 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.26287640 |
| 10 | Hypotrichosis (HP:0001006) | 4.25267310 |
| 11 | Xanthomatosis (HP:0000991) | 4.05539302 |
| 12 | Fragile nails (HP:0001808) | 4.03637656 |
| 13 | Pili torti (HP:0003777) | 3.99532423 |
| 14 | Milia (HP:0001056) | 3.95451905 |
| 15 | Fat malabsorption (HP:0002630) | 3.85452077 |
| 16 | Palmoplantar hyperkeratosis (HP:0000972) | 3.71416910 |
| 17 | Sparse scalp hair (HP:0002209) | 3.49806826 |
| 18 | Palmar hyperkeratosis (HP:0010765) | 3.49239589 |
| 19 | Conjugated hyperbilirubinemia (HP:0002908) | 3.46686242 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.44958486 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.42367697 |
| 22 | Epidermoid cyst (HP:0200040) | 3.29068707 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.24876358 |
| 24 | Prolonged partial thromboplastin time (HP:0003645) | 3.23792665 |
| 25 | Malnutrition (HP:0004395) | 3.15118624 |
| 26 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.11015798 |
| 27 | Oral leukoplakia (HP:0002745) | 3.02446023 |
| 28 | Selective tooth agenesis (HP:0001592) | 3.01507165 |
| 29 | Hyperglycinuria (HP:0003108) | 2.98954284 |
| 30 | Hypolipoproteinemia (HP:0010981) | 2.98442735 |
| 31 | Abnormal hair laboratory examination (HP:0003328) | 2.97839418 |
| 32 | Steatorrhea (HP:0002570) | 2.92019016 |
| 33 | Absent eyelashes (HP:0000561) | 2.90099828 |
| 34 | Parakeratosis (HP:0001036) | 2.88397681 |
| 35 | Dry hair (HP:0011359) | 2.82426275 |
| 36 | Fragile skin (HP:0001030) | 2.82160621 |
| 37 | Ankyloglossia (HP:0010296) | 2.81591706 |
| 38 | * Lip pit (HP:0100267) | 2.77317848 |
| 39 | Palmoplantar keratoderma (HP:0000982) | 2.72595793 |
| 40 | Ketosis (HP:0001946) | 2.72400368 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 2.72158781 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.71688667 |
| 43 | Abnormal blistering of the skin (HP:0008066) | 2.68265660 |
| 44 | Abnormality of nail color (HP:0100643) | 2.67714160 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.67121811 |
| 46 | Ketoacidosis (HP:0001993) | 2.63754913 |
| 47 | Hyperlipoproteinemia (HP:0010980) | 2.62911779 |
| 48 | Complement deficiency (HP:0004431) | 2.61403726 |
| 49 | Hyperglycinemia (HP:0002154) | 2.60050690 |
| 50 | Atrophic scars (HP:0001075) | 2.59121350 |
| 51 | Increased IgE level (HP:0003212) | 2.58729349 |
| 52 | Oligodontia (HP:0000677) | 2.57731108 |
| 53 | Abnormality of permanent molar morphology (HP:0011071) | 2.57590175 |
| 54 | Abnormality of the dental root (HP:0006486) | 2.57590175 |
| 55 | Taurodontia (HP:0000679) | 2.57590175 |
| 56 | Abnormal hemoglobin (HP:0011902) | 2.56965239 |
| 57 | Alopecia of scalp (HP:0002293) | 2.54553158 |
| 58 | Hyperammonemia (HP:0001987) | 2.53044353 |
| 59 | Anonychia (HP:0001798) | 2.52291626 |
| 60 | Abnormality of glycine metabolism (HP:0010895) | 2.52108778 |
| 61 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.52108778 |
| 62 | Hypoplasia of dental enamel (HP:0006297) | 2.51696513 |
| 63 | Aplasia cutis congenita (HP:0001057) | 2.48828410 |
| 64 | Abnormality of the gastric mucosa (HP:0004295) | 2.48403880 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48131467 |
| 66 | Gout (HP:0001997) | 2.43908948 |
| 67 | Nail dystrophy (HP:0008404) | 2.43122111 |
| 68 | Symptomatic seizures (HP:0011145) | 2.41559864 |
| 69 | Hyperglycemia (HP:0003074) | 2.41388199 |
| 70 | Corneal erosion (HP:0200020) | 2.39925461 |
| 71 | Abnormality of molar (HP:0011077) | 2.38856208 |
| 72 | Abnormality of molar morphology (HP:0011070) | 2.38856208 |
| 73 | Dehydration (HP:0001944) | 2.38779298 |
| 74 | Abnormality of the axillary hair (HP:0100134) | 2.38557589 |
| 75 | Abnormality of secondary sexual hair (HP:0009888) | 2.38557589 |
| 76 | Chronic bronchitis (HP:0004469) | 2.37084796 |
| 77 | Vascular calcification (HP:0004934) | 2.36307664 |
| 78 | Generalized aminoaciduria (HP:0002909) | 2.34771878 |
| 79 | Hypercholesterolemia (HP:0003124) | 2.33238132 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.31414239 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 2.29902826 |
| 82 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28236027 |
| 83 | Abnormality of the dental pulp (HP:0006479) | 2.26645465 |
| 84 | Pruritus (HP:0000989) | 2.26404421 |
| 85 | Amelogenesis imperfecta (HP:0000705) | 2.26402340 |
| 86 | Rickets (HP:0002748) | 2.26380047 |
| 87 | Laryngomalacia (HP:0001601) | 2.25363392 |
| 88 | Ventricular tachycardia (HP:0004756) | 2.24903642 |
| 89 | Flat acetabular roof (HP:0003180) | 2.24622266 |
| 90 | Blepharitis (HP:0000498) | 2.23173466 |
| 91 | Amniotic constriction ring (HP:0009775) | 2.23032140 |
| 92 | Abnormality of placental membranes (HP:0011409) | 2.23032140 |
| 93 | Carious teeth (HP:0000670) | 2.22728930 |
| 94 | Sparse eyelashes (HP:0000653) | 2.22318343 |
| 95 | Erythema (HP:0010783) | 2.21746584 |
| 96 | Erythroderma (HP:0001019) | 2.20942879 |
| 97 | Hypoalphalipoproteinemia (HP:0003233) | 2.20411110 |
| 98 | Late onset (HP:0003584) | 2.20323527 |
| 99 | Curly hair (HP:0002212) | 2.19437047 |
| 100 | Advanced eruption of teeth (HP:0006288) | 2.17561857 |
| 101 | Pancreatitis (HP:0001733) | 2.17312716 |
| 102 | Abnormality of the neuromuscular junction (HP:0003398) | 2.16052584 |
| 103 | Fatigable weakness (HP:0003473) | 2.16052584 |
| 104 | Abdominal distention (HP:0003270) | 2.15525581 |
| 105 | Proximal tubulopathy (HP:0000114) | 2.14408089 |
| 106 | Septate vagina (HP:0001153) | 2.14252582 |
| 107 | * Abnormality of the salivary glands (HP:0010286) | 2.11703255 |
| 108 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.08980583 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 2.08656674 |
| 110 | Hydroxyprolinuria (HP:0003080) | 2.08656674 |
| 111 | Acanthosis nigricans (HP:0000956) | 2.07820502 |
| 112 | Abnormality of complement system (HP:0005339) | 2.07431715 |
| 113 | Abnormality of oral frenula (HP:0000190) | 2.05969696 |
| 114 | Hyperhidrosis (HP:0000975) | 2.04609221 |
| 115 | Cardiovascular calcification (HP:0011915) | 2.04481346 |
| 116 | Natal tooth (HP:0000695) | 2.02724282 |
| 117 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.01394656 |
| 118 | Hyperbilirubinemia (HP:0002904) | 2.00674314 |
| 119 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99790768 |
| 120 | * Hypodontia (HP:0000668) | 1.97246477 |
| 121 | * Pterygium (HP:0001059) | 1.96688975 |
| 122 | Hyperactive renin-angiotensin system (HP:0000841) | 1.95952228 |
| 123 | Ectropion (HP:0000656) | 1.95721138 |
| 124 | Hepatocellular carcinoma (HP:0001402) | 1.94858950 |
| 125 | Ileus (HP:0002595) | 1.94690929 |
| 126 | Abnormality of chloride homeostasis (HP:0011422) | 1.94675108 |
| 127 | Thick nail (HP:0001805) | 1.94334064 |
| 128 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94043765 |
| 129 | Conjunctival hamartoma (HP:0100780) | 1.93931681 |
| 130 | Joint hemorrhage (HP:0005261) | 1.93914848 |
| 131 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93405136 |
| 132 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.92615983 |
| 133 | Myocardial infarction (HP:0001658) | 1.91594414 |
| 134 | Cheilitis (HP:0100825) | 1.89208644 |
| 135 | Hyperparathyroidism (HP:0000843) | 1.87930708 |
| 136 | Esophageal varix (HP:0002040) | 1.86335321 |
| 137 | Xerostomia (HP:0000217) | 1.85682856 |
| 138 | Hypohidrosis (HP:0000966) | 1.85166082 |
| 139 | Absent hair (HP:0002298) | 1.84210551 |
| 140 | Abnormality of vitamin metabolism (HP:0100508) | 1.83429177 |
| 141 | * Hypoplastic labia majora (HP:0000059) | 1.83017629 |
| 142 | Abnormality of the fingernails (HP:0001231) | 1.80343376 |
| 143 | Nasolacrimal duct obstruction (HP:0000579) | 1.77759724 |
| 144 | Hoarse voice (HP:0001609) | 1.73535397 |
| 145 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.73277519 |
| 146 | Short nail (HP:0001799) | 1.71471289 |
| 147 | Hyperkalemia (HP:0002153) | 1.68711706 |
| 148 | Rhinitis (HP:0012384) | 1.68079280 |
| 149 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.66047570 |
| 150 | Trismus (HP:0000211) | 1.64325290 |
| 151 | Neonatal death (HP:0003811) | 1.63880476 |
| 152 | Corneal dystrophy (HP:0001131) | 1.63013825 |
| 153 | Follicular hyperkeratosis (HP:0007502) | 1.62024646 |
| 154 | Distal lower limb muscle weakness (HP:0009053) | 1.61285439 |
| 155 | Depressed nasal tip (HP:0000437) | 1.60922365 |
| 156 | Periodontitis (HP:0000704) | 1.59360714 |
| 157 | * Abnormality of the labia majora (HP:0012881) | 1.57183031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.74933151 |
| 2 | MST4 | 3.49633433 |
| 3 | ERN1 | 3.39652051 |
| 4 | MST1R | 3.30266842 |
| 5 | EPHA2 | 3.24738072 |
| 6 | MAP3K2 | 3.22253822 |
| 7 | FGFR4 | 2.92164463 |
| 8 | MAP3K3 | 2.79283881 |
| 9 | MAP3K9 | 2.74585858 |
| 10 | LATS1 | 2.60447316 |
| 11 | TAOK3 | 2.60191795 |
| 12 | MAPK15 | 2.55961226 |
| 13 | FER | 2.55894415 |
| 14 | MAPKAPK3 | 2.54907253 |
| 15 | INSRR | 2.36147541 |
| 16 | BCKDK | 2.32334543 |
| 17 | EPHA3 | 1.97372741 |
| 18 | ARAF | 1.95314311 |
| 19 | SIK1 | 1.82291389 |
| 20 | PTK6 | 1.80040929 |
| 21 | LATS2 | 1.63038515 |
| 22 | NTRK1 | 1.61871528 |
| 23 | CDK12 | 1.51263255 |
| 24 | MAP2K2 | 1.51084800 |
| 25 | MAP3K12 | 1.50138434 |
| 26 | RPS6KB2 | 1.49636847 |
| 27 | FGFR2 | 1.47710558 |
| 28 | PIK3CG | 1.47185488 |
| 29 | MET | 1.42812372 |
| 30 | EPHB2 | 1.37858016 |
| 31 | FGFR3 | 1.28200793 |
| 32 | WNK4 | 1.28196716 |
| 33 | LMTK2 | 1.26326244 |
| 34 | AKT3 | 1.25615895 |
| 35 | MAP3K13 | 1.25599879 |
| 36 | EPHB1 | 1.25289742 |
| 37 | STK38L | 1.23899612 |
| 38 | PAK4 | 1.21438816 |
| 39 | TYK2 | 1.20247674 |
| 40 | RIPK1 | 1.18112298 |
| 41 | MAP3K6 | 1.15874950 |
| 42 | SMG1 | 1.14135391 |
| 43 | DYRK1B | 1.14061107 |
| 44 | PTK2 | 1.11533829 |
| 45 | ERBB2 | 1.09830166 |
| 46 | TRPM7 | 1.04706183 |
| 47 | TRIB3 | 1.03724882 |
| 48 | STK38 | 1.02652334 |
| 49 | NUAK1 | 1.01184929 |
| 50 | MAP3K1 | 1.00964941 |
| 51 | MAP2K6 | 0.96282091 |
| 52 | NEK6 | 0.95648869 |
| 53 | PIM2 | 0.95227937 |
| 54 | ERBB4 | 0.93165485 |
| 55 | LRRK2 | 0.92088582 |
| 56 | IRAK3 | 0.90986985 |
| 57 | NLK | 0.89965684 |
| 58 | NEK9 | 0.87695623 |
| 59 | FLT3 | 0.85759330 |
| 60 | HIPK2 | 0.84825166 |
| 61 | STK39 | 0.84004181 |
| 62 | MAP3K7 | 0.83086048 |
| 63 | BMPR1B | 0.82868933 |
| 64 | TESK1 | 0.82020508 |
| 65 | PRKCI | 0.81189872 |
| 66 | MAP3K14 | 0.79333127 |
| 67 | CDK6 | 0.76707446 |
| 68 | TAOK1 | 0.76587988 |
| 69 | DDR2 | 0.75469964 |
| 70 | STK10 | 0.75202508 |
| 71 | STK3 | 0.73321293 |
| 72 | ERBB3 | 0.72046625 |
| 73 | JAK2 | 0.70368941 |
| 74 | WNK3 | 0.70039355 |
| 75 | GRK1 | 0.69620049 |
| 76 | PKN2 | 0.68199585 |
| 77 | KSR2 | 0.67072989 |
| 78 | PASK | 0.64081127 |
| 79 | STK24 | 0.63817297 |
| 80 | DMPK | 0.60786326 |
| 81 | EEF2K | 0.60346146 |
| 82 | TGFBR1 | 0.59809128 |
| 83 | IKBKE | 0.59653904 |
| 84 | TGFBR2 | 0.57622923 |
| 85 | CHUK | 0.55874429 |
| 86 | PRKD2 | 0.55559470 |
| 87 | MAPK11 | 0.54112669 |
| 88 | PDGFRA | 0.54066772 |
| 89 | CDC42BPA | 0.53846955 |
| 90 | IRAK1 | 0.53597113 |
| 91 | JAK1 | 0.52496984 |
| 92 | RPS6KA2 | 0.50888034 |
| 93 | JAK3 | 0.50485521 |
| 94 | PBK | 0.50277445 |
| 95 | MAP2K1 | 0.50009626 |
| 96 | SGK3 | 0.49533389 |
| 97 | BRAF | 0.47415481 |
| 98 | BMX | 0.47311895 |
| 99 | OXSR1 | 0.45800061 |
| 100 | GSK3A | 0.45309021 |
| 101 | FGFR1 | 0.43567754 |
| 102 | SGK494 | 0.41578644 |
| 103 | SGK223 | 0.41578644 |
| 104 | ICK | 0.41352251 |
| 105 | TBK1 | 0.41182603 |
| 106 | NME1 | 0.41155286 |
| 107 | PRKAA2 | 0.40632075 |
| 108 | ITK | 0.37968801 |
| 109 | ROCK2 | 0.37685302 |
| 110 | RET | 0.37113699 |
| 111 | RPS6KA4 | 0.37046809 |
| 112 | PRKG2 | 0.37007349 |
| 113 | BCR | 0.36166177 |
| 114 | ILK | 0.35921697 |
| 115 | PDGFRB | 0.35530413 |
| 116 | MAP2K3 | 0.33420543 |
| 117 | PIK3CA | 0.32648146 |
| 118 | MYLK | 0.32455410 |
| 119 | RPS6KB1 | 0.31572603 |
| 120 | MAPKAPK2 | 0.31267410 |
| 121 | PDK2 | 0.30266230 |
| 122 | MAPKAPK5 | 0.30025450 |
| 123 | MTOR | 0.29593188 |
| 124 | EIF2AK3 | 0.27557839 |
| 125 | SIK3 | 0.26519794 |
| 126 | ROCK1 | 0.25271785 |
| 127 | WNK1 | 0.25102280 |
| 128 | RPS6KA1 | 0.23949352 |
| 129 | PRKD3 | 0.23790663 |
| 130 | IGF1R | 0.23221756 |
| 131 | PAK3 | 0.23060232 |
| 132 | TIE1 | 0.21613932 |
| 133 | PRKD1 | 0.21086757 |
| 134 | PRKCZ | 0.21031342 |
| 135 | ABL2 | 0.20963669 |
| 136 | CDK9 | 0.20370924 |
| 137 | MAP3K8 | 0.19478192 |
| 138 | PRKCE | 0.18098729 |
| 139 | TTK | 0.17339036 |
| 140 | RAF1 | 0.16859520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.25092779 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22778278 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.06436469 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.72039171 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.67209528 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.59591959 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.54842932 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.40906762 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.35586977 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.28813778 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.28786812 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.26099246 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.25212181 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.21524966 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20373803 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02399086 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.92758562 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.89421473 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.85467259 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74963947 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.71995190 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71927822 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71635913 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70205372 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66621988 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.66509022 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.65790526 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.63209856 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.62499645 |
| 30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.61418730 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.58778590 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47194785 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46987569 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45674331 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44557520 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43480640 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39831591 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.36153386 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35716902 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 1.35545331 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33621100 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.29353535 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.28829523 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28778968 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24887578 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22757188 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19697423 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18899881 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11849414 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00819387 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98632498 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.98609106 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97739749 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97279860 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95998162 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92185073 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89679356 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88357441 |
| 59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85781827 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85091714 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84120804 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81445442 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78229986 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78075087 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77357536 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77318383 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76907978 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.76739245 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.75898939 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75337987 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75040222 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73944236 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73770796 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73166746 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71911877 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71838056 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71553334 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68797969 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67339540 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65541137 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64780926 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63793349 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63533267 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62825969 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62765414 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61024201 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.60885424 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.58657537 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.57786954 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57450371 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57092807 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57004877 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56037576 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55242234 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.53596278 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53524613 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.53480175 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53147495 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51421696 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49344201 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.49259382 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48757646 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47906094 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46196414 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45954407 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45916082 |
| 107 | Adherens junction_Homo sapiens_hsa04520 | 0.45499205 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.45384575 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45232770 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45087462 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43449038 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43344634 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43219827 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.42664945 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42505343 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41330219 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39751913 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39081575 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.38376410 |
| 120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37486343 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35978151 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35556883 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33001501 |
| 124 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32135534 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30169321 |
| 126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29958996 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28174985 |
| 128 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28172294 |
| 129 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25477456 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.24418315 |
| 131 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21905581 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21123625 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17010251 |
| 134 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16119767 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15798077 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15710733 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.14760001 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.13892608 |
| 139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.09925950 |

